Glycomine Funding: $45M Raised, Series B (2019)

Glycomine funding overview

Glycomine is a Biotech company based in San Carlos, CA. Glycomine has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2019. The round record for Glycomine runs through 2019; nothing later has been disclosed. Investors on record include Novo Holdings A/S, Asahi Kasei Pharma Corporation, Mission Bay Capital, Sanderling, Chiesi Ventures. 5 distinct backers are named across the disclosed rounds.

Glycomine at a glance

Total raised: $45M
Latest round: Series B
Latest round date: August 2019
Industry: Biotech
Headquarters: San Carlos, CA
Notable investors: Novo Holdings A/S, Asahi Kasei Pharma Corporation, Mission Bay Capital, Sanderling, Chiesi Ventures

Frequently asked about Glycomine funding

How much has Glycomine raised?: Glycomine has raised $45M in total disclosed funding across the rounds on record.
Who has invested in Glycomine?: Novo Holdings A/S, Asahi Kasei Pharma Corporation, Mission Bay Capital, Sanderling, Chiesi Ventures are named among the investors backing Glycomine.
What was the latest Glycomine funding round?: The most recent disclosed round is a Series B, announced in August 2019.
Where is Glycomine based?: Glycomine is based in San Carlos, CA.
What sector does Glycomine operate in?: Glycomine is tracked under Biotech from San Carlos, CA, with $45M in disclosed funding.
When did Glycomine last raise?: The last disclosed Glycomine round closed in August 2019 at Series B.

Round data for Glycomine is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Carlos and backer lists below.

Glycomine Funding: $45M Raised, Series B (2019)

Glycomine funding overview

Glycomine at a glance

Frequently asked about Glycomine funding

Companies related to Glycomine (40)

Browse related funding lists (4)